nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A practical and immediately available size-match strategy improves short and long term outcomes in lung transplantation
|
Keshavjee, Shaf |
|
|
41 |
9 |
p. 1303 |
artikel |
2 |
Clinical impact of TERT somatic mutation in telomerase-related gene mutation carriers after lung transplantation
|
Ba, Ibrahima |
|
|
41 |
9 |
p. 1207-1209 |
artikel |
3 |
Controlled DCD lung transplantation: Circumventing imagined and real barriers—time for an international taskforce?
|
Siddique, Aleem |
|
|
41 |
9 |
p. 1198-1203 |
artikel |
4 |
Diagnostic yield of genetic testing in heart transplant recipients with prior cardiomyopathy
|
Boen, Hanne M. |
|
|
41 |
9 |
p. 1218-1227 |
artikel |
5 |
Early prediction of failure to progress in single ventricle palliation: A step toward personalizing care for severe congenital heart disease
|
Weisert, Molly |
|
|
41 |
9 |
p. 1268-1276 |
artikel |
6 |
Editorial Board
|
|
|
|
41 |
9 |
p. A1 |
artikel |
7 |
Ethics and the emerging use of pig organs for xenotransplantation
|
Caplan, Arthur |
|
|
41 |
9 |
p. 1204-1206 |
artikel |
8 |
Fourth BNT162b2 vaccination neutralization of omicron infection after heart transplantation
|
Peled, Yael |
|
|
41 |
9 |
p. 1210-1213 |
artikel |
9 |
Genetic cardiomyopathies and clinical implications in heart transplant recipients: An opportunity for missed diagnoses
|
Coniglio, Amanda C. |
|
|
41 |
9 |
p. 1195-1197 |
artikel |
10 |
Information for Readers
|
|
|
|
41 |
9 |
p. A2 |
artikel |
11 |
Intermediate-dose prophylactic anticoagulation with low molecular weight heparin is safe after bioprosthetic artificial heart implantation
|
Smadja, David M. |
|
|
41 |
9 |
p. 1214-1217 |
artikel |
12 |
ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery
|
McGlothlin, Dana P. |
|
|
41 |
9 |
p. 1135-1194 |
artikel |
13 |
Is it too soon to abandon all hope of useful post-transplant predictions in thoracic transplantation? Reply to: Expecting the unexpected, and prioritizing the predictable
|
Dussault, Nicole E. |
|
|
41 |
9 |
p. 1304 |
artikel |
14 |
Lactate during ex-situ heart perfusion does not predict the requirement for mechanical circulatory support following donation after circulatory death (DCD) heart transplants
|
Cernic, Sendi |
|
|
41 |
9 |
p. 1294-1302 |
artikel |
15 |
Prolonged hospital length of stay after pediatric heart transplantation: A machine learning and logistic regression predictive model from the Pediatric Heart Transplant Society
|
Gupta, Dipankar |
|
|
41 |
9 |
p. 1248-1257 |
artikel |
16 |
Real-world experience of Quantiferon-CMV directed prophylaxis in lung transplant recipients
|
Gardiner, Bradley J. |
|
|
41 |
9 |
p. 1258-1267 |
artikel |
17 |
Relationships between 2018 UNOS heart policy and transplant outcomes in metropolitan, micropolitan, and rural settings
|
Breathett, Khadijah |
|
|
41 |
9 |
p. 1228-1236 |
artikel |
18 |
Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation
|
Vicaire, Hugues |
|
|
41 |
9 |
p. 1285-1293 |
artikel |
19 |
Table of Contents
|
|
|
|
41 |
9 |
p. A3-A5 |
artikel |
20 |
The effect of COVID-19 on transplant function and development of CLAD in lung transplant patients: A multicenter experience
|
Roosma, Elizabeth |
|
|
41 |
9 |
p. 1237-1247 |
artikel |
21 |
The U-shaped association of post-lung transplant mortality with pretransplant eGFR underscores possible limitations of creatinine-based estimation equations for risk stratification
|
Kumar, Abhishek |
|
|
41 |
9 |
p. 1277-1284 |
artikel |